Australia's most trusted
source of pharma news
Monday, 29 June 2026
Posted 19 January 2024 AM
A new wave of potential blockbusters or breakthrough medicines has emerged - and five of the 13 top contenders have either been approved in Australia or entered the TGA's regulatory process.
A curated list of drugs and drug candidates forecast to deliver annual sales of more than US$1 billion in 2029 and/or transform treatment paradigms has been compiled by Clarivate in its Drugs to Watch 2024 report.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.